Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results.

Fiche publication


Date publication

juin 2021

Journal

World journal of clinical cases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre


Tous les auteurs :
Adhoute X, Larrey E, Anty R, Chevallier P, Penaranda G, Tran A, Bronowicki JP, Raoul JL, Castellani P, Perrier H, Bayle O, Monnet O, Pol B, Bourliere M

Résumé

Careful selection of hepatocellular carcinoma (HCC) patients prior to chemoembolization treatment is a daily reality, and is even more necessary with new available therapeutic options in HCC.

Mots clés

Barcelona Clinic Liver Cancer, Hepatocellular carcinoma, Pre-TACE-predict, Prognosis, Six-and-twelve, Transarterial chemoembolization

Référence

World J Clin Cases. 2021 Jun 26;9(18):4559-4572